Actym Therapeutics
Berkeley, US · Founded 2017
Biotech
Founders & leadership
KD
Kanad D DasDirector
AD
Amit D KumarDirector, Promoter
JD
James D HuangDirector
CD
Christopher D ThanosExecutive Officer, Director, Promoter
Reported raises · per SEC filings
Form D private placements$11.2MraisedJul 2023 · 5 investors · Biotechnology
Rule 506(b)$14.1MraisedApr 2020 · 28 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.